Sie sind hier: Startseite / Forschung / Ressourcen / Fördermittel und Konsortien

Fördermittel und Konsortien

Wissenschaftlerinnen und Wissenschaftler des Exzellenclusters sind an verschiedenen großen Konsortien nationaler und internationaler Fördereinrichtungen beteiligt.

Ausgewählte Födermittel und Konsortien


  • SFB 877 "Proteolysis as a Regulatory Event in Pathophysiology"
  • SFB 654 "Plasticity and Sleep"
  • SFB/TR22 "Pulmonary Allergies"
  • SFB 841 "Liver Inflammation – Infection, immune regulation and Consequences"
  • KFO 170 "Early Pathogenesis of the Wegner Granulomatose"
  • GRK 1727 "Modulation of Autoimmunity"


  • Popgen 2.0
  • Networks on Resistance and Susceptibility of Infectious Diseases "TBornotTB"
  • International Cancer Genome Consortium "Determination of molecular mechnisms of malignand lymphoma"
  • National Competence Network "Inflammatory Bowel Disease" and "Focus Food Chain Plus"
  • NGFN-Plus "Environment related diseases", "Large intestine cancer" and "Atherogenomics"
  • NanoCare "Prediction of the toxicological potentiel for humans of synthetic Carbon black nano particles"
  • National Cohort
  • Deutsches Zentrum für Lungenforschung
  • Deutsches Zentrum für Infektionsforschung


  • ESGI "European Sequencing and Genotyping Infrastructure"
  • "Clinical Development of Enzyme Replacement Therapy in Alpha-Mannosidosis patients using recombinant human enzyme"
  • ReaDNA "Revolutionary Approaches and Devices for Nucleic Acid analysis"
  • gEuvadis "Genetic European Variation in Disease"
  • RESOLVE "Resolve Chronic Inflammation and Achieve Healthy Aging by Understanding Non-regenerative Repair"
  • Cardiogenics
  • ENGAGE "European Network of Genomic and Genetic Epidemiology"